Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBRUTINIB for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 933 adverse event reports in the FDA FAERS database where IBRUTINIB was used for B-cell lymphoma.

Most Reported Side Effects for IBRUTINIB

Side Effect Reports % Deaths Hosp.
Death 8,007 10.7% 7,998 836
Off label use 5,446 7.3% 866 1,760
Fatigue 4,479 6.0% 203 1,352
Diarrhoea 3,903 5.2% 331 1,322
Atrial fibrillation 3,671 4.9% 407 1,633
Pneumonia 3,015 4.0% 679 2,279
Incorrect dose administered 2,752 3.7% 250 887
Contusion 2,712 3.6% 102 770
Fall 2,375 3.2% 243 1,444
Asthenia 2,200 2.9% 191 1,104
Nausea 2,142 2.9% 146 764
Arthralgia 2,095 2.8% 99 503
Rash 2,029 2.7% 93 487
Haemorrhage 1,907 2.5% 183 461
Disease progression 1,813 2.4% 676 584

Other Indications for IBRUTINIB

Chronic lymphocytic leukaemia (37,003) Product used for unknown indication (15,132) Mantle cell lymphoma (6,306) Waldenstrom's macroglobulinaemia (5,044) B-cell small lymphocytic lymphoma (1,882) Non-hodgkin's lymphoma (1,581) Diffuse large b-cell lymphoma (1,382) Lymphocytic leukaemia (1,308) Lymphoma (896) Marginal zone lymphoma (519)

Other Drugs Used for B-cell lymphoma

RITUXIMAB (7,811) CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) IDELALISIB (1,240)

Related Pages

IBRUTINIB Full Profile All B-cell lymphoma Drugs IBRUTINIB Demographics IBRUTINIB Timeline